Open access
Sep 2026
Orofacial granulomatosis associated with Crohn’s disease: clinical phenotype and response to biologics and Janus kinase inhibitor therapy in a large multi-center cohort
Orofacial granulomatosis is associated with a distinct CD phenotype characterized by frequent UGI and perianal involvement and advanced therapies, including anti-TNF, anti-IL23, and JAKi therapies are effective, with evidence supporting dose optimization.
R. Lees, P. Patel, G. Young et al.
· Journal of Crohn's & Colitis · 0 citations